Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic haemochromatosis.

S B Rosalki1

  • 1OmniLabs, London, UK.

International Journal of Clinical Practice
|November 12, 2002
PubMed
Summary
This summary is machine-generated.

Genetic haemochromatosis is an inherited iron overload disorder caused by HFE gene mutations. Early identification through blood tests and genetic studies is crucial for managing symptoms like fatigue and organ damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbohydrate-deficient transferrin: a marker of alcohol abuse.

International journal of clinical practice·2004
Same author

C-reactive protein.

International journal of clinical practice·2001
Same author

Prostate-specific antigen and prostate cancer.

International journal of clinical practice·2001
Same author

Biochemical identification of alcohol abuse.

International journal of clinical practice·1999
Same author

Porphyria and its investigation.

International journal of clinical practice·1998
Same author

Biochemical markers of bone turnover.

International journal of clinical practice·1998
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Human Physiology

Background:

  • Genetic haemochromatosis is an autosomal recessive inherited disorder affecting iron metabolism.
  • Mutations in the HFE gene are the primary cause.
  • Homozygotes, affecting 1 in 300 in the UK, experience excessive iron absorption.

Purpose of the Study:

  • To outline the genetic basis of haemochromatosis.
  • To describe the clinical manifestations and organ deposition.
  • To detail the diagnostic methods for identifying the condition.

Main Methods:

  • Measurement of serum iron, iron-binding capacity (transferrin), and ferritin levels.
  • Utilizing genetic DNA studies for initial and confirmatory diagnosis.
  • Clinical observation of symptoms in affected individuals.

Related Experiment Videos

Main Results:

  • HFE gene mutations lead to excessive intestinal iron absorption.
  • Iron deposition in organs such as the liver, heart, and pancreas can occur.
  • Symptoms include fatigue, arthritis, cardiac failure, diabetes, and skin pigmentation, predominantly in males over 50.

Conclusions:

  • Genetic haemochromatosis is a significant inherited metabolic disorder.
  • Accurate diagnosis relies on biochemical markers and genetic testing.
  • Timely identification and management are essential to prevent severe organ damage and associated diseases.